(Q44000025)

28 November 2017

Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial (English)

1 reference

28 November 2017

0 references

1 reference

Arthur T Evans

1

1 reference

28 November 2017

Shahid Husain

2

1 reference

28 November 2017

Lakshmi Durairaj

3

1 reference

28 November 2017

Laura S Sadowski

4

1 reference

28 November 2017

Marjorie Charles-Damte

5

1 reference

28 November 2017

Yue Wang

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

359

1 reference

28 November 2017

1648-1654

1 reference

28 November 2017

9318

1 reference

Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Control of antimicrobial resistance: time for action. The essentials of control are already well known

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Uncomplicated acute bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Randomised controlled trial of antibiotics in patients with cough and purulent sputum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Antibiotics in acute bronchitis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Azithromycin compared with clarithromycin in the treatment of adult patients with acute purulent tracheobronchitis: a cost of illness study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Symptomatic effect of inhaled fenoterol in acute bronchitis: a placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Measuring quality of life in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

A measure of quality of life for clinical trials in chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Development and testing of a new measure of health status for clinical trials in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Interpretation of rhinoconjunctivitis quality of life questionnaire data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Interpreting treatment effects in randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Assessing the minimal important difference in symptoms: a comparison of two techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Comparative analysis of two rates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Acute bronchitis: course of symptoms and restrictions in patients' daily activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

Open randomised trial of prescribing strategies in managing sore throat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

What will it take to stop physicians from prescribing antibiotics in acute bronchitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908597-5

7 January 2021

10.1016/S0140-6736(02)08597-5

Identifiers

DOI

1 reference

28 November 2017

1 reference